Clinical Trial Update: Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed [Phase 4]

View source ↗

Summary

A Phase 4 multicenter, randomized, double-blind, double-dummy trial comparing once-daily esomeprazole 20 mg to lansoprazole 15 mg for six months in patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis

Drugs mentioned

• Esomeprazole (Esomeprazole)
• Lansoprazole (Lansoprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Erosive Esophagitis | Phase 4 | Status: COMPLETED